Abstract Myelodysplasia in children is rare. We report two cases presenting with pancytopaenia and macrocytosis with additional features suggestive of Fanconi anemia which is an autosomal recessive disorder in which there is progressive bone marrow failure and increased predisposition to malignancies especially AML. Hypersensitivity of FA cells to the chromosome-breaking effect of crosslinking agents provides a reliable cellular marker for the diagnosis of this disorder.
Introduction
Pediatric myelodysplasia are rare and difficult to classify. The 2008 World Health Organization (WHO) classification system has now formally recognized the unique nature of childhood myelodysplasia syndrome. Myelodysplastic syndrome (MDS) accounts for less than 5 % of all hemopoietic neoplasms in patients below 14 years of age. Primary MDS should be distinguished from MDS associated with inherited or acquired bone marrow failure (BMF) syndromes and therapy related MDS [1] . Fanconi anaemia (FA) is an inherited BMF syndrome associated with MDS and other solid tumors. We are reporting 2 cases of paediatric MDS. Clinical diagnosis in both were FA.
Case Report
Case No 1 A 3 year old male child was referred to the paediatric department with febrile siezures and diarrhea. On examination there was severe pallor, circumoral hyperpigmentation and café au lait spots. The height of the patient was 89 cm and X-ray of the wrist showed decreased bone age and only three carpal bones. There was no hepatosplenomegaly. Patient had a tendency to develop pyoderma. Haemogram revealed pancytopaenia. Hemoglobin was 7.6 g/dl with raised mean corpuscular volume (MCV) of 107 fl (Fig. 1) . Total count was 2.46 9 10 3 /ml and platelets 21.6 9 10 3 /ml. Bone marrow examination showed hypocellularity with a focal collection of megaloblasts and dyserythropoiesis with nuclear budding and bridging. Myeloid series were relatively decreased and did not show dysplastic features. Megakaryocytes were also very few but definite dysplastic features were not noted. Bone marrow blast count was less than 5 %.
Case No 2
A 10 year old boy presented with fever and vomiting. Patient was short for his age with microcephaly. There were severe pallor, circumoral hyperpigmentation, café au lait spots and history of developmental delay. Hemogram and peripheral smear showed pancytopaenia with hemoglobin value of 3.4 g/dl, total count of 3.19 9 10 with MCV of 108 fl. A few pseudo Pelger-Huet cells were noted. Bone marrow smears showed megaloblasts, dyserythropoietic cells with nuclear irregularities and budding and hypogranular myeloid cells. Megakaryocytes were reduced but not appreciably dysplastic. Blast count was less than 5 % (Figs. 2, 3 ). Bone marrow biopsy showed scanty material. Diagnosis of FA was provisionally made.
Bone marrow picture of the first patient is suggestive of refractory anemia except for the peripheral blood picture of pancytopenia which is invariable in a BMF syndrome like FA. The second patient has pancytopenia and dysplasia of two myeloid lineages and hence can be classified as refractory cytopenia with multilineage dysplasia. Refractory cytopaenia of childhood (RCC) is difficult to differentiate from congenital BMF syndromes based on bone marrow picture and needs confirmation of the latter by special tests.
As our institution does not have facilities for cytogenetics and other investigations to confirm Fanconi anemia, both patients were advised to attend referral centres for further investigations and management. For both boys diagnosis was confirmed with positive stress cytogenetics. Both patients are currently on prednisolone and stanozolol along with folic acid supplements.
Discussion
The term MDS refers to a group of clonal stem cell disorders characterized by maturation defects that are associated with ineffective haemopoiesis and a high risk of transformation to acute myeloid leukemia (AML). Paediatric MDS may be associated with FA, Down syndrome, NF 1 mutation, Bloom syndrome etc. Non neoplastic causes like medications, metabolic diseases, infectious diseases can also cause myelodysplasia in children. Infantile megaloblastic anaemia presenting as pancytopaenia may be misinterpreted as myelodysplasia [2] . Primary paediatric MDS cannot always be classed into adult categories of MDS. Hence WHO has included a category called RCC which shows persistent cytopaenia and blast count of less than 2 % in peripheral blood and less than 5 % in bonemarrow. No ring sideroblasts are seen. 75 % of cases show hypocellular marrow and hence is difficult to differentiate from congenital BMF syndromes based on bone marrow picture alone [1] .
FA was first described by Guido Fanconi in 1927. It is an autosomal recessive disorder in which there is progressive BMF and increased predisposition to malignancies especially AML.
FA patients often, but not always, present with a combination of various congenital abnormalities (short stature; thumb and radius deformities; microphthalmia and peculiar facies; skin hyperpigmentation, such as café-au-lait spots; cardiac, renal, genitourinary and/or other malformations [3, 4] . Both our patients had hyperpigmentation and café au lait spots. Second boy had short stature and microcephaly.
Most FA patients develop BMF usually in the first or second decade of life. Thrombocytopenia is often associated with elevated levels of fetal hemoglobin and macrocytosis and usually precedes onset of anemia or neutropenia. Notably, some patients present with MDS or AML [5] .
Hypersensitivity of FA cells to the chromosome-breaking effect of cross-linking agents provides a reliable cellular marker for the diagnosis of this disorder. Diepoxybutane (DEB) and mitomycin C (MMC) are the agents most widely used for FA diagnosis. Importantly, the clinician should know that the chromosomal breakage test could also be applied to the study of fetal cells obtained by chorionic villus sampling, amniocentesis, or percutaneous umbilical blood sampling [5] . It is also important to identify cases early for family counseling and treatment [4] .
Both our patients presented with pancytopaenia and myelodysplasia. The clinical features pointed to FA in both cases. It is important to identify myelodysplasia in such patients as morphologic MDS may be more important than cytogenetics in prediction of adverse outcome in cases of FA [6] .
